Across 19 studies in asymptomatic, average-risk adults, FIT detected colorectal cancer with pooled sensitivity of 79% and specificity of 94%; a single sample performed about as well as several.
Finger-prick, stool, saliva and swab kits you collect at home and post to a lab. Some are reliable; many panels outrun the evidence, and results need a clinician.
At-home kits let you collect a sample yourself (a few drops of fingertip blood on a card or in a small tube, a stool sample, saliva, urine or a swab) and post it to a laboratory. Some are ordered by your own clinician; direct-to-consumer kits are bought online, often with a company-contracted doctor signing the order.
Two separate questions decide whether a result is worth anything. Is the lab good (in the US, certified under CLIA, ideally also accredited)? And is the sample good enough for that test? A posted finger-prick sample can match a vein draw for some markers and be poor for others.
Some home tests are well proven: stool immunochemical tests (FIT) caught about 79% of colorectal cancers with 94% specificity in a meta-analysis. Posted, self-collected finger-prick samples agreed closely with vein draws for HbA1c, creatinine and cholesterol in a 105-person study, but for blood counts, successive fingertip drops varied up to several times more than venous blood. Whether consumer test panels improve health is unproven, and laboratory-medicine reviews warn of over-testing and misread results.
Across 19 studies in asymptomatic, average-risk adults, FIT detected colorectal cancer with pooled sensitivity of 79% and specificity of 94%; a single sample performed about as well as several.
In 105 people, self-collected capillary samples sent by ordinary post agreed closely with couriered venous samples for HbA1c (mean bias 0.03%) and creatinine, and well for LDL, HDL and total cholesterol (relative bias 3–6%).
In successive drops from a single fingerprick, variation in hemoglobin, white cell and platelet counts was up to 3–8 times greater than in venous blood, so single-drop measurements should be treated with caution.
Laboratory-medicine experts describe how consumer-ordered tests fall outside healthcare protections, how marketing can mislead, and conclude that such testing helps in a few selected situations but risks medicalising healthy people.